Every material Form 8-K Central Garden & Pet has filed with the SEC since September 27, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Central Garden & Pet said John D. Walker will retire as President, Garden Consumer Products, effective September 26, 2026. The filing does not name a successor or describe the reasons for the retirement.
John D. Walker is retiring as President, Garden Consumer Products.
The retirement is effective September 26, 2026.
The company announced the change on September 21, 2026.
The filing does not name a successor or give financial figures.
Central Garden & Pet reported fiscal 2026 third-quarter net sales of $882 million, down 8% from $961 million, while organic net sales rose 2%. The company raised its fiscal 2026 non-GAAP diluted EPS outlook to $2.85 or better from $2.70 or better, and agreed after quarter-end to acquire an 80% interest in TRIXIE for €340 million in cash at closing plus up to €60 million in earn-out payments.
Q3 net sales were $882 million versus $961 million, down 8%; organic net sales rose 2% to $862 million versus $842 million.
Q3 GAAP diluted EPS was $1.45 versus $1.52; non-GAAP diluted EPS was $1.54 versus $1.56.
Fiscal 2026 non-GAAP diluted EPS outlook raised to $2.85 or better from $2.70 or better.
Agreed to acquire 80% of TRIXIE for €340 million in cash at closing plus up to €60 million in earn-out payments; closing is expected in the first half of fiscal 2027.
Central Garden & Pet reported fiscal 2026 second-quarter net sales of $906 million, up from $834 million a year earlier, and GAAP diluted EPS of $1.28, up from $0.98. The company reaffirmed its fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better and said it entered a pet distribution partnership with Phillips after the quarter, in which Central keeps a 20% stake. The results are preliminary until the company files its Form 10-Q.
Net sales $906 million vs. $834 million; operating income $114 million vs. $93 million.
GAAP diluted EPS $1.28 vs. $0.98; non-GAAP diluted EPS $1.29 vs. $1.04.
Fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better reaffirmed.
Central to retain a 20% stake in the new pet distribution business; Phillips and its investors hold 80%.
On February 11, 2026, Central Garden & Pet's board approved a $100 million increase in the company's share repurchase authorization, bringing the total to approximately $127 million as of that date. The same day, shareholders elected nine directors, ratified Deloitte & Touche LLP as auditor, and approved the advisory vote on executive pay. The filing also discloses the appointment of Kay M. Schwichtenberg to the board, effective March 1, 2026.
Board approved a $100 million increase to the share repurchase authorization on February 11, 2026; total authorization is approximately $127 million as of that date.
Company press release states management considers the market price of its shares to be currently undervalued.
Kay M. Schwichtenberg appointed to the board effective March 1, 2026, and to the Audit Committee; she retired as Executive Vice President, Animal & Public Health in February 2023.
Shareholders approved the executive compensation advisory vote with 16,346,943 votes for and 218,084 against.
Central Garden & Pet reported fiscal 2026 first-quarter results with net sales of $617 million, down from $656 million, and GAAP diluted EPS of $0.11, down from $0.21. Non-GAAP diluted EPS was $0.21, flat with a year earlier, and the company reaffirmed its fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better. The company said the results are preliminary until it files its Form 10-Q, and the Garden segment swung to an operating loss.
Net sales were $617 million versus $656 million a year earlier, which management partly attributed to shipment timing and portfolio optimization.
GAAP diluted EPS was $0.11 versus $0.21; non-GAAP diluted EPS was $0.21, flat year over year.
Garden segment posted an operating loss of $10 million versus operating income of $2 million a year earlier.
Fiscal 2026 non-GAAP diluted EPS outlook of $2.70 or better was reaffirmed; the company has not yet filed its Form 10-Q for the quarter ended December 27, 2025.
Central Garden & Pet reported fiscal 2025 net sales of $3.1 billion, down from $3.2 billion, while GAAP diluted EPS rose to $2.55 from $1.62 and non-GAAP diluted EPS rose to $2.73 from $2.13. The company expects fiscal 2026 non-GAAP EPS of $2.70 or better, which is slightly below the fiscal 2025 non-GAAP result, and the results are preliminary until its Form 10-K is filed.
Fiscal 2025 net sales were $3.1 billion versus $3.2 billion, a decrease of 2%.
Fiscal 2025 GAAP diluted EPS was $2.55 versus $1.62; non-GAAP diluted EPS was $2.73 versus $2.13.
Fourth-quarter net sales were $678 million versus $669 million, and the net loss narrowed to $10 million from $34 million.
Fiscal 2026 outlook calls for non-GAAP EPS of $2.70 or better and capital spending of $50 million to $60 million.
Central Garden & Pet signed a Fourth Amended and Restated Credit Agreement on November 7, 2025, providing a $600 million senior secured asset-based revolving credit facility that matures November 7, 2030. The company did not draw any commitments at closing, and the facility can be increased by up to an additional $400 million if lenders agree, which gives the company borrowing capacity for general corporate purposes.
Facility size: $600 million revolver, with up to $400 million more available through an uncommitted accordion feature
Maturity: November 7, 2030; replaces the Third Amended and Restated Credit Agreement dated December 16, 2021
No borrowings drawn at closing; pricing at closing was SOFR plus 1.00% on SOFR-based loans
Secured by substantially all assets of the company and guarantor subsidiaries, with a minimum fixed charge coverage ratio of 1.00:1.00 when triggered
Central Garden & Pet reported fiscal third-quarter 2025 results for the period ended June 28, 2025. Net sales fell 4% to $961 million, while GAAP diluted earnings per share rose to $1.52 from $1.19, helped by gross margin expansion from its Cost and Simplicity program. The company reaffirmed its fiscal 2025 non-GAAP EPS outlook of approximately $2.60.
Net sales were $961 million, down 4%; Pet segment sales fell 3% and Garden segment sales fell 4%.
GAAP diluted EPS was $1.52 vs. $1.19 a year earlier; non-GAAP diluted EPS was $1.56 vs. $1.32.
Gross margin expanded 280 basis points to 34.6%; the company repurchased 1.7 million shares for $55 million in the quarter.
Fiscal 2025 non-GAAP EPS outlook of approximately $2.60 was reaffirmed, not changed.
Central Garden & Pet said on July 11, 2025 that it raised its fiscal 2025 non-GAAP earnings per share outlook to approximately $2.60, citing margin expansion from its Cost and Simplicity initiatives and a favorable product mix. The filing does not state the prior outlook, so the size of the increase cannot be determined from this document. The company also cautioned that its fourth quarter is seasonally small and that consumer demand remains uncertain.
Fiscal 2025 non-GAAP EPS outlook raised to approximately $2.60 for the fiscal year ending September 28, 2025
Company expects fiscal 2025 capital expenditures of approximately $60 million
Outlook excludes the potential impact of further tariff changes and any acquisitions, divestitures, or restructuring
Additional details to be provided on the fiscal 2025 third-quarter earnings call on August 6, 2025
Central Garden & Pet reported fiscal second-quarter 2025 results for the period ended March 29, 2025. Net sales fell 7% to $834 million, while GAAP diluted EPS rose to $0.98 from $0.93, and the company reaffirmed its fiscal 2025 non-GAAP EPS outlook of $2.20 or better, which matters to shareholders because sales declined even as per-share earnings grew.
Net sales were $834 million, down 7%; Pet segment sales fell 6% to $454 million and Garden segment sales fell 10% to $380 million.
GAAP diluted EPS was $0.98 versus $0.93 a year earlier; non-GAAP diluted EPS was $1.04 versus $0.99.
Fiscal 2025 non-GAAP EPS outlook was reaffirmed at $2.20 or better.
Central repurchased $41 million of stock during the quarter and $39 million more through April 30, 2025, with $63 million remaining available.
At its February 12, 2025 annual meeting, shareholders elected all ten director nominees and ratified Deloitte & Touche LLP as the independent auditor for fiscal 2025. The filing also discloses fiscal 2024 cash bonuses approved February 11, 2025, which were left out of the proxy statement because the amounts had not yet been set.
Christopher T. Metz received 13,980,186 votes for and 5,321,592 withheld, the weakest support among the ten nominees.
Deloitte & Touche LLP was ratified with 19,566,205 votes for and 268,191 against.
Non-equity incentive pay for fiscal 2024 includes $920,000 for Mary Beth Springer and $341,000 for John Hanson; the Board withdrew Proposal Three on an officer exculpation amendment.
Central Garden & Pet reported first quarter fiscal 2025 results for the period ended December 28, 2024, with net sales up 3% to $656 million and EPS of $0.21 versus $0.01 a year earlier. The company kept its fiscal 2025 non-GAAP EPS outlook of $2.20 or better, but management said the quarter benefited from the timing of shipments and promotions.
Net sales rose 3% to $656 million from $635 million a year ago; net income was $14 million versus $0.4 million.
Gross margin improved 160 basis points to 29.8%; operating income rose to $28 million from $8 million.
Cash used by operations was $69 million; the company repurchased $52 million of stock, with $131 million remaining under its authorization.
Fiscal 2025 non-GAAP EPS outlook of $2.20 or better was maintained, excluding acquisitions, divestitures or restructuring.
Central Garden & Pet's Board approved a $100 million increase to its share repurchase authorization, bringing the total to about $130 million as of December 11, 2024. The company said it considers its stock undervalued and expects repurchases to be funded from cash on hand and borrowings, which could affect cash available for other uses and shareholder returns.
Board approved a $100 million increase in the repurchase authorization on December 11, 2024
Total repurchase authorization is approximately $130 million following the increase
Program has no expiration date and may be increased, modified, suspended, or terminated at any time
Randal D. Lewis, former Spectrum Brands Executive Vice President and Chief Operating Officer, joined the Board effective December 11, 2024
Central Garden & Pet reported fiscal 2024 net sales of $3.2 billion, down 3% from $3.3 billion, with GAAP diluted EPS of $1.62 versus $1.88 a year earlier and non-GAAP diluted EPS of $2.13 versus $2.07. The company expects fiscal 2025 non-GAAP EPS of $2.20 or better, while fourth-quarter results included a net loss of $34 million.
Fiscal 2024 net sales were $3.2 billion, down 3%; organic net sales fell 4%.
Fourth-quarter net sales were $669 million, down 11%, and the company posted a GAAP net loss of $34 million, or $0.51 per diluted share.
Fiscal 2025 non-GAAP EPS is expected to be $2.20 or better, according to the company's outlook.
Cash and cash equivalents were $754 million at September 28, 2024, compared with $489 million a year earlier.
Central Garden & Pet said Nicholas Lahanas, its chief financial officer since May 2017, will become chief executive and a board member effective September 29, 2024, replacing interim CEO Mary Beth Springer, who resigned effective September 28 and remains on the board. Bradley G. Smith, previously chief financial officer of the Pet Segment, will become chief financial officer on the same date. The filing discloses pay terms for both executives but no financial results.
Nicholas Lahanas becomes CEO effective September 29, 2024, with an annual base salary of $900,000, a 100% target bonus from fiscal 2025, and a target annual equity grant of $1,000,000.
Lahanas resigns as CFO effective September 28, 2024; Bradley G. Smith, age 58, becomes CFO effective September 29, 2024, with a $450,000 base salary, a 50% target bonus and a $250,000 target equity grant.
Interim CEO Mary Beth Springer resigned effective September 28, 2024, and will remain on the Board of Directors.
Both executives have at-will employment and 24-month post-employment consulting agreements, with Lahanas paid $3,432 monthly and Smith $2,500 monthly.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Central Garden & Pet filing is on SEC EDGAR ↗. 8-K briefs of other companies →